VC-backed CytomX Therapeutics files for IPO

South San Francisco-based CytomX Therapeutics, a biopharmaceutical company focused on treating cancer, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be determined. The company plans on trading the stock on the NASDAQ under the ticker symbol “CTMX.” BofA Merrill Lynch, Jefferies LLC and Cowen and Company LLC will serve as the lead underwriters. CytomX’s backers include Fidelity Management & Research Company, Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners and Wellington Management Company.

162 Views

Arlington Capital to sell Novetta to Carlyle

The Carlyle Group has agreed to acquire McLean, Virginia-based Novetta, a provider of advanced analytics solutions, from Arlington Capital Partners. No financial terms were disclosed. Morgan Stanley & Co LLC and Houlihan Lokey provided financial advice to Novetta and Arlington Capital Partners on the transaction while Jefferies was financial advisor to Carlyle.

150 Views

Thoma Bravo to buy majority stake in DigiCert

Thoma Bravo LLC has agreed to acquire a majority stake in Lehi, Utah-based DigiCert, a provider of trusted certificate management solutions. The seller is TA Associates, which will retain a minority stake in DigiCert as part of the transaction. No financial terms were disclosed. Jefferies LLC provided financial advice to Thoma Bravo while Evercore did likewise for DigiCert. Jefferies Finance LLC and Fifth Street Asset Management provided the financing for the deal.

274 Views

Apax to acquire controlling stake in FULLBEAUTY Brands

Apax Partners has agreed to acquire a controlling stake in FULLBEAUTY Brands, a provider of plus-size apparel. The sellers are Charlesbank Capital Partners and Webster Capital; however, Charlesbank will retain a “substantial” ownership stake in FULLBEAUTY after the transaction closes. No financial terms were disclosed. J.P. Morgan Securities LLC and Jefferies provided financial advice to FULLBEAUTY, Charlesbank and Webster Capital while Deutsche Bank did likewise for Apax.

227 Views

Apax to invest in online real estate marketplace Idealista

Apax Partners has agreed to acquire a stake in online real estate marketplace Idealista SA. The sellers are Tiger Global Management, Kutxabank and Bonsai Venture Capital. Jefferies provided financial advice to Idealista on the transaction while PricewaterhouseCoopers provided financial and tax advice to Apax.

291 Views

Jefferies hires Green, Carey

Jefferies said Tuesday that it has hired Rex H. Green and Jonathan A. Carey as Managing Directors and Global Co-Heads of Automotive Aftermarket Investment Banking. Green was most recently MD responsible for a number of investment banking groups at BB&T Capital Markets. Carey was most recently also an MD and Head of the Automotive Aftermarket investment banking practice at BB&T Capital Markets.

145 Views

Harvest completes DCA acquisition from Quad-C

Harvest Partners has acquired DCA Investment Holding LLC, a dental support organization in the U.S. The seller was Quad-C Management Inc. No financial terms were disclosed. Jefferies LLC advised Harvest while Houlihan Lokey advised DCA. In addition to the funding, Ira Kleinman, Jay Wilkins and Paige Daly have been added to DCA’s board of directors.

302 Views

Insight Venture Partners to buy Fourth

ECI Partners has agreed to sell a majority stake of Fourth to Insight Venture Partners. Financial terms weren’t announced. London-based Fourth provides cloud-based (SaaS) cost control solutions to the hospitality industry. Jefferies advised Fourth/ECI Partners.

143 Views

VC-backed ProNAi files for IPO

Vancouver-based ProNAi Therapeutics, a developer of nucleic acid therapeutics, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The stock will list on the NASDAQ under the ticker symbol “DNAI.” Jefferies LLC and BofA Merrill Lynch will serve as the lead underwriters. ProNAi’s backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.

176 Views

PE-backed Patheon files for IPO

Durham, North Carolina-based Patheon, a provider of outsourced pharmaceutical development and manufacturing services, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. J.P. Morgan, Morgan Stanley, Jefferies and UBS are serving as the lead underwriters. Patheon is owned by JLL Partners and Royal DSM.

177 Views

PE-owned Fogo de Chão sets IPO pricing terms

Brazilian steakhouse chain Fogo de Chão Inc has priced its over 4.41 million shares of its IPO at between $16 and $18 per share. The stock will list on the NASDAQ under the ticker symbol “FOGO.” Jefferies LLC and J.P. Morgan Securities LLC are serving as the lead underwriters. Fogo is owned by Thomas H. Lee Partners.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget